Cancer risk in patients hospitalised for Graves disease: A population-based cohort study in Sweden

British Journal of Cancer

Volumn 102, Issue 9, 2010, Pages 1397-1399

  Shu, X ^a,b   Ji, J ^b   Li, X ^b   Sundquist, J ^b,c   Sundquist, K ^a   Hemminki, K ^a,b,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Hospital Discharge Registry; Hyperthyroidism; Subsequent cancer

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; COLON CANCER; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAVES DISEASE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; NONHODGKIN LYMPHOMA; PARATHYROID ADENOMA; PRIORITY JOURNAL; SWEDEN; THYROID CANCER;

BREAST NEOPLASMS; COHORT STUDIES; COLONIC NEOPLASMS; FEMALE; GRAVES DISEASE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; LYMPHOMA, NON-HODGKIN; MALE; MELANOMA; MOUTH NEOPLASMS; NEOPLASMS; PARATHYROID NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SWEDEN; THYROID NEOPLASMS;

EID: 77951665363     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605624     Document Type: Article

References (27)

1. Abraham-Nordling M, Torring O, Lantz M, Hallengren B, Ohrling H, Lundell G, Calissendorff J, Jorneskog G, Wallin G (2008) Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005. Eur J Endocrinol 158: 823-827
2. Angusti T, Codegone A, Pellerito R, Favero A (2000) Thyroid cancer prevalence after radioiodine treatment of hyperthyroidism. J Nucl Med 41: 1006-1009
3. Brent GA (2008) Clinical practice. Graves' disease. N Engl J Med 358: 2594-2605
4. Brix TH, Kyvik KO, Christensen K, Hegedus L (2001) Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86: 930-934
5. Cole WH (1991) Incidence of carcinoma of the thyroid in nodular goiter. Semin Surg Oncol 7: 61-63
6. Costenbader KH, Karlson EW (2006) Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus 15: 737-745
7. Cristofanilli M, Yamamura Y, Kau SW, Bevers T, Strom S, Patangan M, Hsu L, Krishnamurthy S, Theriault RL, Hortobagyi GN (2005) Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 103: 1122-1128
8. de la Cruz-Merino L, Grande-Pulido E, Albero-Tamarit A, Codes-Manuel de Villena ME (2008) Cancer and immune response: old and new evidence for future challenges. Oncologist 13: 1246-1254
9. Delellis RA, Lloyd RV, Heitz PU, Eng C (2004) Pathology and Genetics of Tumours of Endocrine Organs. IARC Press: Lyon
10. Ellerhorst JA, Sendi-Naderi A, Johnson MK, Cooke CP, Dang SM, Diwan AH (2006) Human melanoma cells express functional receptors for thyroid-stimulating hormone. Endocr Relat Cancer 13: 1269-1277
11. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P (1999) Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 353: 2111-2115
12. Goldman MB, Monson RR, Maloof F (1990) Cancer mortality in women with thyroid disease. Cancer Res 50: 2283-2289
13. Hancock SL, McDougall IR, Constine LS (1995) Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 31: 1165-1170
14. Hemminki K, Li X, Sundquist J, Sundquist K (2008) Cancer risks in ulcerative colitis patients. Int J Cancer 123: 1417-1421
15. Ito K, Maruchi N (1975) Breast cancer in patients with Hashimoto's thyroiditis. Lancet 2: 1119-1121
16. Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K (2009) Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden. Ann Oncol 20: 1121-1126
17. Lantz M, Abraham-Nordling M, Svensson J, Wallin G, Hallengren B (2009) Immigration and the incidence of Graves' thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma. Eur J Endocrinol 160: 201-206
18. Majima T, Komatsu Y, Doi K, Shigemoto M, Takagi C, Fukao A, Kojima M, Tamaki H, Ito J, Nakao K (2005) Anaplastic thyroid carcinoma associated with Graves' disease. Endocr J 52: 551-557
19. Munoz JM, Gorman CA, Elveback LR, Wentz JR (1978) Incidence of malignant neoplasms of all types of patients with Graves' disease. Arch Intern Med 138: 944-947
20. Nilsson IL, Zedenius J, Yin L, Ekbom A (2007) The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy. Endocr Relat Cancer 14: 135-140
21. Norenstedt S, Ekbom A, Brandt L, Zedenius J, Nilsson IL (2009) Postoperative mortality in parathyroid surgery in Sweden during five decades: improved outcome despite older patients. Eur J Endocrinol 160: 295-299
22. Nomura AM (1982) Association of cigarette smoking and nitrosamines with urinary bladder cancer: a review. Natl Cancer Inst Monogr 62: 185-190
23. Pazaitou-Panayiotou K, Perros P, Boudina M, Siardos G, Drimonitis A, Patakiouta F, Vainas I (2008) Mortality from thyroid cancer in patients with hyperthyroidism: the Theagenion Cancer Hospital experience. Eur J Endocrinol 159: 799-803
24. Prestwich RJ, Errington F, Hatfield P, Merrick AE, Ilett EJ, Selby PJ, Melcher AA (2008) The immune system-is it relevant to cancer development, progression and treatment? Clin Oncol (R Coll Radiol) 20: 101-112
25. Ringold DA, Nicoloff JT, Kesler M, Davis H, Hamilton A, Mack T (2002) Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study. Thyroid 12: 647-653
26. Smyth PP, Shering SG, Kilbane MT, Murray MJ, McDermott EW, Smith DF, O'Higgins NJ (1998) Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 83: 2711-2716
27. Stalberg P, Svensson A, Hessman O, Akerstrom G, Hellman P (2008) Surgical treatment of Graves' disease: evidence-based approach. World J Surg 32: 1269-1277